Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Managing Erectile Dysfunction in Patients With Cardiovascular Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors
American Journal of Lifestyle Medicine, 05/13/09
Cheng JWM et al. - Patients with cardiovascular disease have a high prevalence of erectile dysfunction. Recent evidence demonstrated that erectile dysfunction is an early indication of coronary artery disease. Phosphodiesterase-5 (PDE-5) inhibitors when used together with nitrates or other vasodilators such as alpha-antagonists may cause hypotension. Clinical studies demonstrated that in patients with stable coronary artery disease, heart failure, and hypertension controlled by medications who were not receiving nitrates, PDE-5 inhibitors were well tolerated. PDE-5 inhibitors are absolutely contraindicated with concurrent nitrate use. No PDE-5 inhibitors should be administered within 12 hours after the last nitrate dose. If a patient develops chest pain while taking PDE-5 inhibitors, nitrates should be administered only after the PDE-5 inhibitors have been washed out of the system, based on the half-life of individual agents (washed-out period for sildenafil 20 hours; vardenafil 24 hours; tadalafil 88 hours). If symptomatic hypotension occurs, patients should be put in a Trendelenburg position. Fluid resuscitation therapy and alpha-agonists should be used to support blood pressure, if necessary.
Related Articles
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 70%
Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09
Relevance Score: 69%
Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 69%
New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09
Relevance Score: 68%
The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/08/09
Clinical aspects and epidemiology of uncomplicated cystitis in women-German results of the ARESC Study
Der Urologe, 12/08/09
Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies
Urology, 12/07/09
Today in Erectile Dysfunction...keeping you current
Receive free subspecialty "5-minute updates" via email
Association Analysis of Endothelial Nitric Oxide Synthase G894T Gene Polymorphism and Erectile Dysfunction Complaints in a Population-Based Survey
The Journal of Sexual Medicine, 12/08/09
The International Index of Erectile Function: Development of an Adapted Tool for Use in HIV-Positive Men Who Have Sex with Men
The Journal of Sexual Medicine, 12/07/09
Orgasmic Dysfunction After Open Radical Prostatectomy: Clinical Correlates and Prognostic Factors
The Journal of Sexual Medicine, 12/07/09
Article Search
Sponsor


See Latest Articles


